α-Bungarotoxin Receptor in a Human Neuroblastoma Cell Line

  • C. Gotti
  • E. Sher
  • D. Fornasari
  • B. Chini
  • A. Esparis Ogando
  • F. Clementi
Conference paper
Part of the NATO ASI Series book series (volume 25)


The nicotinic acetylcholine receptor (AChR) is a neurotransmitter receptor which, upon acetylcholine binding, undergoes a conformational change, which triggers ion permeability by opening a self contained cation channel. AChr is present in muscle end plates, in ganglia and in the Central Nervous System (CNS), with different structural and functional characteristics. The most complete information on structure and function are available for AChR of skeletal muscles and fish electric organs (Conti-Tronconi and Raftery, 1982; Popot and Changeux, 1984). In the muscle receptor five subunits (α2, β, γ, δ) are arranged with pseudo-five-fold symmetry around the central cation conducting channel. Of the five subunits only the two a-subunits bind acetylcholine and cholinergic agents.


Nicotinic Receptor Nicotinic Acetylcholine Receptor Sedimentation Coefficient IMR32 Cell Human Neuroblastoma Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abbracchio MP, Cattabeni F., Clementi F, Sher E. Adenosine receptors linked to adenylate cyclase activity in human neuroblastoma cells: modulation during cell differentation. Neuroscience, submitted.Google Scholar
  2. Breer H, Kleene R, Hinz G (1985) Molecular forms and subunit structure of the acetylcholine receptor in the central nervous system of insects. J Neurosci 5:3386–3392PubMedGoogle Scholar
  3. Chiappinelli VA, Cohen JB, Zigmond RE (1981) The effects of alpha- and beta-neurotoxins from the venoms of various snakes on transmission in autonomic ganglia. Brain Res 211:107–126PubMedCrossRefGoogle Scholar
  4. Chiappinelli VA (1985) Actions of snake venom toxins on neuronal nicotinic receptors and other neuronal receptors. Pharmacol Ther 31:1–32PubMedCrossRefGoogle Scholar
  5. Chang Chiung (1979) The action of snake venom on nerve and muscle. In: Snake Venoms, Lee C-Y (ed) Handbook of Experimental Pharmacology, Springer Verlag, Berlin, 52:309–376Google Scholar
  6. Clarke PBS, Schwartz RD, Paul SM, Pert CB, Pert A (1985) Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [3H]-alpha-bungarotoxin. J Neurosci 5: 1307–1315.PubMedGoogle Scholar
  7. Clementi F, Cabrini D, Gotti C, Sher E (1986) Pharmacological characterization of cholinergic receptors in a human neuroblastoma cell line. J Neurochem 47:291–297PubMedCrossRefGoogle Scholar
  8. Cocchia D, Fumagalli G (1981) Immunocytochemical localization of alpha-bungarotoxin receptors in the chick ciliary ganglion: synaptic and extrasynaptic sites? Neurochem Int 3:123–128PubMedCrossRefGoogle Scholar
  9. Coiro V, Butturini V, Gundi A, Delsignore R, Volpi R, Chiodera P (1986) Nicotinic-cholinergic involvment in arginine-vasopressin response to insulin-induced hypoglicemia in normal men. Metabolism 35:577–579PubMedCrossRefGoogle Scholar
  10. Conti-Tronconi BM, Dunn SJ, Barnard EA, Dolly JO, Lay FA, Ray N, Raftery MA (1985) Brain and muscle nicotinic acetylcholine receptors are different but homologous proteins. Proc Natl Acad Sci USA 82:5208–5212PubMedCrossRefGoogle Scholar
  11. Conti-Tronconi BM, Raftery MA (1982) The nicotinic cholinergic receptor: correlation of molecular structure with functional properties. Ann Rev Biochem 51:491–530PubMedCrossRefGoogle Scholar
  12. de la Garza R, Hoffer B, Freeman R (1988) Heterogeneity of nicotine actions in the rat cerebellum. In: Nicotinic acetylcholine receptors in the nervous system, Clementi F et al (eds), Springer Verlag, Berlin, pp.Google Scholar
  13. Freeman JA, Schmidt JT, Oswald RE (1980) Effect of alpha-bungarotoxin on retinorectal synaptic transmission in the gold fish and toad. Neuroscience 5:929–942.PubMedCrossRefGoogle Scholar
  14. Gotti C, Sher E, Cabrini D, Bondiolotti G, Wanke E, Mancinelli E, Clementi F (1987) Cholinergic receptors, ion channels, neurotransmitter synthesis and neurite out-growth are independently regulated during the in vitro differentiation of a human neuroblastoma cell line. Differentiation 34: 144–155PubMedCrossRefGoogle Scholar
  15. Gotti C, Sher E, Chini B, Foraasari D, Esparis Ogando A, Clementi F (1988) The nicotinic receptors in the nervous system. Pharmacol Res Comm, in pressGoogle Scholar
  16. Gregg CM (1985) The compartmentalized hypothalamus. Neurohypophyseal action of acetylcholine on vasopressin release. Neuroendocrinology 40:423–429.CrossRefGoogle Scholar
  17. Hall GH (1984) Pharmacological responses to the intracerebral administration of nicotine. In: Nicotine and the tobacco smoking habit, Balfour DKJ (ed) Encyclopedia Pharm Ther, Pergamon Press, New York, pp.45–60Google Scholar
  18. Hanke W, Breer H (1986) Channel properties of a neuronal acetylcholine receptor isolated from the nervous system of insects reconstituted in planar lipid bilayer. Nature 321:171–174PubMedCrossRefGoogle Scholar
  19. Kemp G, Bentley L, McNamee M, Morley B (1985) Purification and characterization of the alpha-bungarotoxin binding protein from rat brain. Brain Res 347:274–283.PubMedCrossRefGoogle Scholar
  20. Lauffer L and Hucho F (1982) Triphenylmethylphosphonium is an ion channel ligand of the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 79:2406–2409PubMedCrossRefGoogle Scholar
  21. Lindstrom J, Whiting P, Schoepfer R, Luther M, Casey B (1988) Structure of neuronal nicotinic receptors. In: Nicotinic acetylcholine receptors in the nervous system, Clementi F et al (eds), Springer Verlag, Berlin, pp.Google Scholar
  22. Loring RH, Dahm LM, Zigmond RE (1985) Localization of alpha-bungarotoxin binding sites in the ciliary ganglion of the embryonic chick: an autoradiographic study at the light and electron microscopic level. Neuroscience 14: 645–660PubMedCrossRefGoogle Scholar
  23. Marks MJ, Stitzel JA, Collins AC (1987) Influence of kinetics of nicotine administration on tolerance development and receptor levels. Pharmacol Biochem Behav 27:505–512PubMedCrossRefGoogle Scholar
  24. Martin RB (1986) Nicotine Receptors in the Central Nervous System. In: The receptors, vol 3, Conn PM (ed) Academic Press, New York, pp 393–415Google Scholar
  25. Morley BJ, Kemp GE (1981) Characterization of a putative nicotinic acetylcholine receptor in mammalian brain. Brain Res Rev 3:81–104.CrossRefGoogle Scholar
  26. Oswald RE, Freeman JA (1981) Alpha-bungarotoxin binding and central nervous system acetylcholine receptors. Neuroscience 6:1–14PubMedCrossRefGoogle Scholar
  27. Perry EK (1986) The cholinergic hypothesis — ten years on. Brit Med Bull 42: 63–69PubMedGoogle Scholar
  28. Popot PL and Changeux JP (1984) Nicotinic receptor of acetylcholine: structure of an oligomeric integral membrane protein. Phys Rev 64:1162–1239Google Scholar
  29. Ravdin BM, Berg DK (1979) Inhibition of neuronal acetylcholine sensitivity by alpha-toxin from Bungarus multicinctus venom. Proc Natl Acad Sci USA 76:2072–2076.PubMedCrossRefGoogle Scholar
  30. Ross RA, Tong Hyub J, Reis DJ, Spengler BA, Biedler JL (1980) Neurotransmitter-synthesizing enzymes in human neuroblastoma cells: relationship to morphology diversity. In: Progress in Cancer Research, Evans AE (ed), Raven Press, New York, pp.151–160Google Scholar
  31. Rupniak MT, Rein G, Powell JF, Ryder TA, Carson S, Povey S, Hill BT (1984) Characteristics of a new human neuroblastoma cell line which differentiates in response to cyclic adenosine 3′:5′-monophosphate. Cancer Res 44, 2600–2607PubMedGoogle Scholar
  32. Sattelle DB, David JA, Harrow ID, Hue B (1980) Actions of alpha-bungarotoxin on identified central neurones. In: Receptors for neurotransmitter, hormones and pherormones, Sattelle DB (ed) Elsevier, Amsterdam, pp. 125–139Google Scholar
  33. Shershen H, Hashin A, Lajtha A (1987) Behavioural and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson’s disease. Pharmacol Biochem Behav 28: 299–303CrossRefGoogle Scholar
  34. Whiting PJ, Liu R, Morley B, Lindstrom JM (1987a) Structurally different neuronal nicotinic acetylcholine receptor subtypes purified and characterized using monoclonal antibodies. J Neurosci 7:4005–4016PubMedGoogle Scholar
  35. Whiting PJ, Schoepfer R, Swanson LW, Simmons DM, Lindstrom JM (1987b) Functional acetylcholine receptor in PC12 cells reacts with monoclonal antibody to brain nicotinic receptors. Nature 327:515–517PubMedCrossRefGoogle Scholar
  36. Wonnacott S (1987) Brain nicotine binding sites. Human Toxicol 6:343–353CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • C. Gotti
    • 1
  • E. Sher
    • 1
  • D. Fornasari
    • 1
  • B. Chini
    • 1
  • A. Esparis Ogando
    • 1
  • F. Clementi
    • 1
  1. 1.Department of Medical Pharmacology, CNR Center of CytopharmacologyUniversity of MilanMilanItaly

Personalised recommendations